Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,477.10
-8.30 (-0.56%)
Feb 16, 2026, 11:49 AM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 376.85 billion as of February 13, 2026. Its market cap has increased by 2.97% in one year.
Market Cap
376.85B
Enterprise Value
391.48B
Revenue
95.06B
Ranking
n/a
PE Ratio
41.01
Stock Price
1,477.10
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 376.85B, an increase of 11,608.03%. That is a compound annual growth rate of 22.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 376.85B | 4.69% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mankind Pharma | 850.58B |
| Aurobindo Pharma | 665.37B |
| Alkem Laboratories | 645.95B |
| Glenmark Pharmaceuticals | 563.72B |
| Laurus Labs | 545.58B |
| Ajanta Pharma | 364.68B |
| Gland Pharma | 293.40B |
| Emcure Pharmaceuticals | 282.22B |